Personal Information
Entreprise/Lieu de travail
Munich Area, Germany Germany
Profession
MD, Precision Medicine leader, visionary technology, innovation and business model expert
Secteur d’activité
Medical / Health Care / Pharmaceuticals
Site Web
www.innventis.com
À propos
MD, physician, 25+ years in R&D.
Enables PRECISION MEDICINE by morphing omics (Big DATA in genomics, proteomics, metabolomics, clinical data, literatur mining) in a vertically integrated business model with a focus on inflammatory chronic disabling disease; see SlideShare below.
Development of therapeutic concepts and business through converging technologies including mobile/wireless, ICT in conjunction with biomedical R&D and new Dx; i.e. morphing Medtec, Pharma/Biotech with mobile ICT (algorithms/machine learning).
"Reverse Innovation":
A priori integrating local customer needs and resources in the conception and design of innovative health care solutions.
"Symbiotic Innovation": O...
Mots-clés
digital health
personalized medicine
precision medicine
drug discovery
biotechnology and pharmaceuticals
biomarker
reverse innovation
theranostics
diagnostics
mhealth
machine learning
drug development
r&d
disruptive innovation
translational medicine
research & development
pattern discovery
pattern recognition
artificial intelligence
clinical trial
symbiotic innovation
open innovation
big data
metabolomics
multi-omics
omics
precsion medicine
non-communicable diseases
diabetes
mobile ict
mobile computing
clinical trials
emerging markets
Tout plus
Présentations
(11)Personal Information
Entreprise/Lieu de travail
Munich Area, Germany Germany
Profession
MD, Precision Medicine leader, visionary technology, innovation and business model expert
Secteur d’activité
Medical / Health Care / Pharmaceuticals
Site Web
www.innventis.com
À propos
MD, physician, 25+ years in R&D.
Enables PRECISION MEDICINE by morphing omics (Big DATA in genomics, proteomics, metabolomics, clinical data, literatur mining) in a vertically integrated business model with a focus on inflammatory chronic disabling disease; see SlideShare below.
Development of therapeutic concepts and business through converging technologies including mobile/wireless, ICT in conjunction with biomedical R&D and new Dx; i.e. morphing Medtec, Pharma/Biotech with mobile ICT (algorithms/machine learning).
"Reverse Innovation":
A priori integrating local customer needs and resources in the conception and design of innovative health care solutions.
"Symbiotic Innovation": O...
Mots-clés
digital health
personalized medicine
precision medicine
drug discovery
biotechnology and pharmaceuticals
biomarker
reverse innovation
theranostics
diagnostics
mhealth
machine learning
drug development
r&d
disruptive innovation
translational medicine
research & development
pattern discovery
pattern recognition
artificial intelligence
clinical trial
symbiotic innovation
open innovation
big data
metabolomics
multi-omics
omics
precsion medicine
non-communicable diseases
diabetes
mobile ict
mobile computing
clinical trials
emerging markets
Tout plus